Clinical Relevance (Real-World Perspective) Animal studies are suggestive of a potential of AOD 9604 in supporting weight loss
Percutaneous procedures such as radiofrequency rhizotomy, balloon compression, or glycerol rhizolysis may cause facial numbness, unpleasant tingling or dysesthesia, painful numbness known as anesthesia dolorosa, reduced corneal sensation, weakened blink reflex, masseter weakness, chewing difficulty, hematoma, vascular injury, cerebrospinal fluid leakage, infection, temporary cranial nerve dysfunction, incomplete pain relief, or recurrence
Weight Regulation In animal studies, AOD-9604 reduced body fat mass and improved metabolic parameters. Early human trials showed limited direct weight loss, but trends toward improved lipid metabolism. Key takeaway: May influence weight management indirectly by altering fat metabolism
The volume of the injection, in milliliters (mL) , can change based on the solutions concentration
Vitamin B can also decrease serum levels of certain anticonvulsant medications
2d-f) and weighted (Supplementary Fig